1.      Allen CE, Merad M, McClain KL. Langerhans-cell histiocytosis. N Engl J Med. 2018;379:856-868.

2.      Antonescu CR. Molecular pathology of vascular tumors. Histopathology. 2014;64:85-97.

3.      Atherton DJ. Neonatal and Pediatric Dermatology. 2nd ed. Oxford: Oxford University Press; 2004:379-386.

4.      Bolognia JL, Schaffer JV, Cerroni L. Dermatology. 4th ed. Philadelphia: Elsevier; 2018:1879-1896.

5.      Bolognia JL, Schaffer JV, Cerroni L. Dermatology. 5th ed. Elsevier; 2021:2035-2048.

6.      Bower M, et al. Kaposi sarcoma management. Br J Haematol. 2014;165:286-295.

7.      Bravo MT, Garmendia M, Blanco SB, Etxezarraga C, Paja M. Langerhans cell histiocytosis: a rare cause of cholestasis in adult patients. Rev Esp Enferm Dig. 2010;102:571-572.

8.      Calonje E, Brenn T, Lazar A, Billings SD. McKee’s Pathology of the Skin. 5th ed. Philadelphia: Elsevier; 2019:1705-1718.

9.      Dabska M. Malignant endovascular papillary angioendothelioma. Cancer. 1969;24:503-510.

10.  Dehner LP. Juvenile xanthogranulomas in childhood. Am J Surg Pathol. 2003;27:579-593.

11.  Dehner LP. Juvenile xanthogranulomas in the first two decades of life. Am J Surg Pathol. 2003;27(5):579-593.

12.  DiCaprio MR, Roberts TT. Diagnosis and management of Langerhans cell histiocytosis. J Am Acad Orthop Surg. 2014;22:643-652.

13.  Dishop MK, et al. Plexiform fibrohistiocytic tumor in children. Pediatr Dev Pathol. 2003;6:60-69.

14.  Donadieu J, Chalard F, Jeziorski E. Medical management of Langerhans cell histiocytosis from diagnosis to treatment. Expert Opin Pharmacother. 2012;13:1309-1322.

15.  Drolet BA, et al. Kasabach-Merritt phenomenon. Pediatrics. 2013;131:e1362-e1368.

16.  Elder DE, Elenitsas R, Johnson BL, Murphy GF. Lever’s Histopathology of the Skin. 11th ed. Philadelphia: Wolters Kluwer; 2015:867-882.

17.  Elder DE, Massi D, Scolyer RA, Willemze R. WHO Classification of Skin Tumours. 4th ed. IARC; 2018:240-256.

18.  Emile JF, Abla O, Fraitag S, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016;127(22):2672-2681.

19.  Enzinger FM, Zhang RY. Plexiform fibrohistiocytic tumor. Am J Surg Pathol. 1988;12:818-826.

20.  Fanburg-Smith JC, et al. Composite hemangioendothelioma. Am J Surg Pathol. 2002;26:1482-1490.

21.  Fanburg-Smith JC, et al. Retiform hemangioendothelioma. Am J Surg Pathol. 1998;22:1135-1145.

22.  Ferrari A, et al. Undifferentiated pleomorphic sarcoma in children. Pediatr Blood Cancer. 2011;56:235-241.

23.  Fetsch JF, et al. Angiomatoid fibrous histiocytoma. Cancer. 1998;82:1999-2012.

24.  Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F. WHO Classification of Tumours of Soft Tissue and Bone. 5th ed. Lyon: IARC; 2020:278-301.

25.  Fletcher CDM, et al. WHO Classification of Soft Tissue Tumours. 5th ed. Lyon: IARC; 2020:152-173.

26.  Frieden IJ, Howard R. Pediatric Dermatology. 5th ed. Philadelphia: Elsevier; 2021:1449-1462.

27.  Gantt S, et al. Pediatric Kaposi sarcoma. Pediatr Blood Cancer. 2010;54:795-801.

28.  Gianotti R, Caputo R. Dermoscopy of juvenile xanthogranuloma. Arch Dermatol. 2007;143(9):1222.

29.  Grifo AH. Langerhans cell histiocytosis in children. J Pediatr Oncol Nurs. 2009;26:41-47.

30.  Hallor KH, et al. Molecular genetics of angiomatoid fibrous histiocytoma. Am J Pathol. 2009;174:970-977.

31.  Haroche J, Cohen-Aubart F, Rollins BJ, et al. Histiocytoses: emerging neoplasia behind inflammation. Lancet Oncol. 2017;18(2):e113-e125.

32.  Hornick JL, et al. Pseudomyogenic hemangioendothelioma. Am J Surg Pathol. 2011;35:190-201.

33.  ISSVA Classification of Vascular Anomalies. 2025 update.

34.  Janssen D, Harms D. Juvenile xanthogranuloma: clinicopathologic characteristics of 129 cases. Histopathology. 2005;46(5):467-476.

35.  Jezierska M, Stefanowicz J, Romanowicz G, Kosiak W, Lange M. Langerhans cell histiocytosis in children—a disease with many faces. Postepy Dermatol Alergol. 2018;35:6-17.

36.  Kliegman RM, St. Geme JW. Nelson Textbook of Pediatrics. 21st ed. Elsevier; 2020.

37.  Krooks J, Minkov M, Weatherall AG. Langerhans cell histiocytosis in children: history, classification, pathobiology, clinical manifestations, and prognosis. J Am Acad Dermatol. 2018;78:1035-1044.

38.  Leung AK, Chan KW. Iron deficiency anemia. Adv Pediatr. 2001;48:385-408.

39.  Leung AKC, Lam JM, Leong KF. Childhood Langerhans cell histiocytosis: a disease with many faces. World J Pediatr. 2019;15(6):536-545.

40.  Lyons LL, et al. Kaposiform hemangioendothelioma. Am J Surg Pathol. 2004;28:559-568.

41.  McClain K. Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis. 2015.

42.  McClain KL, Bigenwald C, Collin M, et al. Histiocytic disorders. Nat Rev Dis Primers. 2021;7:73.

43.  McClain KL. Treatment of Langerhans cell histiocytosis. UpToDate. 2019.

44.  Mehta B, Amladi S. Langerhans cell histiocytosis presenting as hypopigmented papules. Pediatr Dermatol.

45.  Monsereenusorn C, Rodriguez-Galindo C. Clinical characteristics and treatment of Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 2015;29:853-873.

46.  Morimoto A, Oh Y, Shioda Y, Kudo K, Imamura T. Recent advances in Langerhans cell histiocytosis. Pediatr Int. 2014;56:451-461.

47.  Myers DJ, et al. Dermatofibroma. StatPearls. Published 2024.

48.  Nicollas R, Guelfucci B, Roman S, et al. Congenital cysts and fistulas of the neck. Int J Pediatr Otorhinolaryngol. 2000;55(2):117-124.

49.  North PE, et al. Pediatric vascular tumors: diagnostic approach. J Am Acad Dermatol. 2016;75:120-135.

50.  Papadopoulou M, Panagopoulou P, Papadopoulou A, et al. The multiple faces of Langerhans cell histiocytosis in childhood: A gentle reminder. Mol Clin Oncol. 2018;8(3):489-492.

51.  Pensler JM, Bauer BS, Naidich TP. Craniofacial dermoids. Plast Reconstr Surg. 1988;82(6):953-958.

52.  Perkins JA, et al. Malignant vascular tumors in children. Pediatr Dev Pathol. 2018;21:205-219.

53.  Perkins JA, Manning SC, Tempero RM, et al. Lymphatic malformations: current cellular and clinical investigations. Pediatrics. 2010;126(5):e1135-e1143.

54.  Pettinger KJ, Solman L, Mathew B, Taylor G, Clark S, Picton S. Cutaneous Langerhans cell histiocytosis presenting in a neonate. Arch Dis Child. 2018;103:993.

55.  Prasad S, Grundfast K, Milmoe G. Management of preauricular sinus. J Pediatr Surg. 1990;25(2):214-216.

56.  Requena L, et al. Cutaneous epithelioid angiosarcoma. J Am Acad Dermatol. 2018;78:102-110.

57.  Requena L, Kutzner H. Retiform hemangioendothelioma. J Cutan Pathol. 2003;30:125-134.

58.  Requena L, Kutzner H. Vascular tumors of intermediate malignancy. Semin Diagn Pathol. 2013;30:62-80.

59.  Rockwell PG. Digital mucous cysts. Am Fam Physician. 2001;64(12):1987-1990.

60.  Shulman K, El-Azhary RA. Juvenile xanthogranuloma: clinical and dermoscopic findings. Pediatr Dermatol. 2017;34(4):429-433.

61.  Spunt SL, et al. Pediatric soft tissue sarcomas. Cancer. 2002;95:149-159.

62.  Tanas MR, et al. WWTR1–CAMTA1 fusion in epithelioid hemangioendothelioma. Genes Chromosomes Cancer. 2011;50:644-652.

63.  Thacker NH, Abla O. Pediatric Langerhans cell histiocytosis: state of the science and future directions. Clin Adv Hematol Oncol. 2019;17:122-131.

64.  Weedon D. Weedon’s Skin Pathology. 5th ed. Elsevier; 2021:927-945.

65.  Weiss SW, et al. Epithelioid hemangioendothelioma. Am J Surg Pathol. 1986;10:754-764.

66.  Weitzman S, Jaffe R. Non-Langerhans cell histiocytoses: a clinical review. Br J Haematol. 2005;129(4):433-445.

67.  Yu J, Rubin AI, Castelo-Soccio L, Perman MJ. Congenital self-healing Langerhans cell histiocytosis. J Pediatr. 2017;184:232-232.e1.

68.  Zelger B, et al. Juvenile xanthogranuloma: clinicopathologic study. Histopathology. 1995;26:509-520.